Yuval Cohen retweeted
A Novel Cisplatin-Based Prodrug Inhibits Lysine Deacetylases, Suppresses Nucleotide Excision Repair, and Overcomes Resistance biorxiv.org/cgi/content/shor… #biorxiv_molbio
Yuval Cohen retweeted
New preprint! A fun collaboration lead by Yaara Negev Korem, with Ron Kohen and Dan Gibson from @PharmacyHUJI and Ori Wald from @Hadassah_Med ! We synthesized a novel cisplatin-based prodrug, in which cisplatin is fused to two KDAC inhibitors. Check it out:
@IMRIC_HUJ @Hujimed
A Novel Cisplatin-Based Prodrug Inhibits Lysine Deacetylases, Suppresses Nucleotide Excision Repair, and Overcomes Resistance biorxiv.org/cgi/content/shor… #biorxiv_molbio
Yuval Cohen retweeted
Check out our latest paper on the transcriptional response to bulky DNA damage! What's new? First: What's true for UV isn't necessarily true for other bulky damages. Second...
life-science-alliance.org/co…
I'm thrilled to see it published! Big thanks to my supportive PI @sheeradar for the opportunity!
Our review in @repair_dna on recent insights into bulky DNA damage formation and NER regulation is out! Really enjoyed writing this with the talented @yuvalcohen2
authors.elsevier.com/a/1hZ7%…